FASTENAL CO
FASTENAL CO demonstrates strong profitability and capital allocation, supported by consistent revenue and net profit growth averaging over 8% and 10% respectively. The company also exhibits excellent financial health with a low debt-to-equity ratio and high current ratio. However, its current valuation metrics, such as PE and PB ratios, are high, suggesting the stock might be overvalued relative to its calculated fair value.
Business Performance (CAGR)
Valuation Snapshot
Financial Health
Profitability Metrics
Cash Flow Intelligence
Intrinsic Value
PremiumEstimated Intrinsic Value & DCF Fair Value are available with Premium plans.
AI Business Verdict
FASTENAL CO is a highly profitable and financially strong company with a consistent track record of growth and excellent capital allocation. However, its current market valuation appears elevated compared to its intrinsic value, indicating that the market may already be pricing in its strong fundamentals. Long-term value creation potential is strong, but current entry points should be carefully considered.
- Exceptional profitability with high ROE (31.91%) and ROCE (40.68%).
- Very strong financial health, exemplified by a Debt-to-Equity ratio of 0.03 and Current Ratio of 8.20.
- Consistent and robust growth in revenue (8.42% CAGR) and net profit (10.81% CAGR).
- Superior free cash flow generation with a CAGR of 13.83% and strong OCF to PAT conversion.
Balance Sheet
FASTENAL CO maintains a balanced sheet with adequate liquidity and manageable leverage.
Capacity to fund growth, withstand downturns and return capital.
- FASTENAL CO maintains a balanced sheet with adequate liquidity and manageable leverage.
- Net cash position — debt fully covered by cash & investments
- Very low leverage with net cash balance
- Comfortable short-term liquidity cushion
- Long working capital cycle
- Slow book value compounding